Medgenics Company Profile (NASDAQ:MDGN)

About Medgenics (NASDAQ:MDGN)

Medgenics logo

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: N/A
  • Sub-Industry: N/A
  • Symbol: NASDAQ:MDGN
  • CUSIP: N/A
  • Web: www.medgenics.com
Average Prices:
  • 50 Day Moving Avg: $5.23
  • 200 Day Moving Avg: $5.54
  • 52 Week Range: $3.09 - $6.60
P/E:
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -4.35
  • P/E Growth: 0.00
Profitability:
  • Return on Equity: -85.70%
  • Return on Assets: -78.57%
Debt:
  • Current Ratio: 8.71%
  • Quick Ratio: 8.71%
Misc:
  • Average Volume: 185,272 shs.
  • Beta: 1.17
 

Frequently Asked Questions for Medgenics (NASDAQ:MDGN)

What is Medgenics' stock symbol?

Medgenics trades on the NASDAQ under the ticker symbol "MDGN."

How were Medgenics' earnings last quarter?

Medgenics Inc (NASDAQ:MDGN) posted its earnings results on Thursday, August, 4th. The company reported ($0.69) EPS for the quarter, missing the consensus estimate of ($0.30) by $0.39. View Medgenics' Earnings History.

Where is Medgenics' stock going? Where will Medgenics' stock price be in 2017?

4 brokerages have issued 12-month price objectives for Medgenics' shares. Their predictions range from $12.00 to $14.00. On average, they anticipate Medgenics' stock price to reach $13.00 in the next twelve months. View Analyst Ratings for Medgenics.

Who are some of Medgenics' key competitors?

How do I buy Medgenics stock?

Shares of Medgenics can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Medgenics stock cost?

One share of Medgenics stock can currently be purchased for approximately $5.57.

Analyst Ratings

Consensus Ratings for Medgenics (NASDAQ:MDGN) (?)
Ratings Breakdown: 4 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $13.00 (133.39% upside)

Analysts' Ratings History for Medgenics (NASDAQ:MDGN)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
12/6/2016HC WainwrightInitiated CoverageBuy$14.00N/AView Rating Details
11/4/2016JMP SecuritiesReiterated RatingBuyN/AView Rating Details
9/23/2016Jefferies Group LLCInitiated CoverageBuyN/AView Rating Details
6/7/2016Needham & Company LLCReiterated RatingBuy$12.00N/AView Rating Details
(Data available from 5/25/2015 forward)

Earnings

Earnings History for Medgenics (NASDAQ:MDGN)
Earnings by Quarter for Medgenics (NASDAQ:MDGN)
Earnings History by Quarter for Medgenics (NASDAQ:MDGN)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/3/2016Q316($0.30)($0.29)ViewN/AView Earnings Details
8/4/2016Q2($0.30)($0.69)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Medgenics (NASDAQ:MDGN)
Current Year EPS Consensus Estimate: $-1.26 EPS
Next Year EPS Consensus Estimate: $-1.28 EPS

Dividends

Dividend History for Medgenics (NASDAQ:MDGN)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Medgenics (NASDAQ:MDGN)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Headline Trends for Medgenics (NASDAQ:MDGN)
Latest Headlines for Medgenics (NASDAQ:MDGN)
Source:
DateHeadline
americanbankingnews.com logoMedgenics (MDGN) Getting Somewhat Positive Media Coverage, Analysis Shows
www.americanbankingnews.com - April 30 at 8:28 AM
americanbankingnews.com logoMedgenics (MDGN) Receives Daily Media Impact Score of -0.22
www.americanbankingnews.com - April 24 at 1:58 PM
americanbankingnews.com logoMedgenics (MDGN) Receiving Somewhat Favorable News Coverage, Analysis Finds
www.americanbankingnews.com - April 21 at 12:14 AM
americanbankingnews.com logoMedgenics (MDGN) Receiving Somewhat Favorable News Coverage, Report Shows
www.americanbankingnews.com - April 17 at 3:54 PM
finance.yahoo.com logoCoverage initiated on Medgenics by H.C. Wainwright
finance.yahoo.com - December 6 at 9:58 AM
cnbc.com logoMedgenics reports 3Q loss
www.cnbc.com - November 3 at 6:07 PM
biz.yahoo.com logoMEDGENICS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
biz.yahoo.com - November 3 at 6:07 PM
rttnews.com logoILMN Fails To Light Up, MDGN Leaves The Big Board For Nasdaq, Watch Out For SUPN
www.rttnews.com - October 11 at 6:22 PM
finance.yahoo.com logoMDGN: Several Upcoming Milestones Including NFC-1 ADHD Phase 2/3 Data
finance.yahoo.com - August 9 at 6:21 PM

Social

Chart

Medgenics (MDGN) Chart for Thursday, May, 25, 2017

This page was last updated on 5/25/2017 by MarketBeat.com Staff